Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$555M |
| 2 |
Citigroup
C
|
+$407M |
| 3 |
Medtronic
MDT
|
+$401M |
| 4 |
Chipotle Mexican Grill
CMG
|
+$392M |
| 5 |
Gilead Sciences
GILD
|
+$362M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.43B |
| 2 |
Amazon
AMZN
|
+$1.32B |
| 3 |
Apple
AAPL
|
+$1.1B |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$995M |
| 5 |
Bank of America
BAC
|
+$726M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.02% |
| 2 | Healthcare | 2.92% |
| 3 | Consumer Discretionary | 2.17% |
| 4 | Financials | 2.1% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5151
PUT
Nabors Industries
NBR
$1.39B
| $2.35M | ﹤0.01% |
36,500
+18,500
| +103% | +$1.43M |
|
5152
PUT
BlueLinx
BXC
$680M
| $2.35M | ﹤0.01% |
22,300
+5,900
| +36% | +$603K |
|
5153
PUT
Brookfield Asset Management
BAM
$86.7B
| $2.35M | ﹤0.01% |
49,690
-66,900
| -57% | -$2.8M |
|
5154
Core Laboratories
CLB
$571M
| $2.35M | ﹤0.01% |
126,777
+49,242
| +64% | +$989K |
|
5155
CALL
Ardelyx
ARDX
$1.05B
| $2.35M | ﹤0.01% |
340,800
+147,200
| +76% | +$869K |
|
5156
PUT
Polaris
PII
$3.95B
| $2.35M | ﹤0.01% |
28,200
-98,100
| -78% | -$7.97M |
|
5157
CALL
Natural Resource Partners
NRP
$1.39B
| $2.35M | ﹤0.01% |
24,000
-19,300
| -45% | -$1.76M |
|
5158
Oil States International
OIS
$539M
| $2.34M | ﹤0.01% |
509,584
-340,783
| -40% | -$1.63M |
|
5159
CALL
ProShares UltraShort QQQ
QID
$245M
| $2.34M | ﹤0.01% |
64,800
+47,820
| +282% | +$1.88M |
|
5160
CALL
Elanco Animal Health
ELAN
$11.8B
| $2.34M | ﹤0.01% |
159,500
-46,800
| -23% | -$652K |
|
5161
PUT
MakeMyTrip
MMYT
$5.68B
| $2.34M | ﹤0.01% |
25,200
+3,200
| +15% | +$302K |
|
5162
Colliers International
CIGI
$5.39B
| $2.34M | ﹤0.01% |
15,417
+2,250
| +17% | +$306K |
|
5163
Arbutus Biopharma
ABUS
$924M
| $2.34M | ﹤0.01% |
607,744
+462,869
| +319% | +$1.78M |
|
5164
CALL
Encompass Health
EHC
$12.2B
| $2.34M | ﹤0.01% |
24,200
-5,900
| -20% | -$530K |
|
5165
CALL
Honda
HMC
$41B
| $2.34M | ﹤0.01% |
73,700
+50,700
| +220% | +$1.61M |
|
5166
CALL
Plexus
PLXS
$7.13B
| $2.34M | ﹤0.01% |
17,100
+4,100
| +32% | +$498K |
|
5167
PUT
ARS Pharmaceuticals
SPRY
$562M
| $2.34M | ﹤0.01% |
161,200
+111,000
| +221% | +$1.32M |
|
5168
Expensify
EXFY
$210M
| $2.34M | ﹤0.01% |
1,191,942
-89,604
| -7% | -$186K |
|
|
JKS
5169
PUT
JinkoSolar
JKS
$877M
| $2.34M | ﹤0.01% |
87,100
+24,300
| +39% | +$489K |
|
|
BASE
5170
DELISTED
Couchbase
BASE
| $2.33M | ﹤0.01% |
144,772
-77,138
| -35% | -$1.34M |
|
5171
Kadant
KAI
$3.95B
| $2.33M | ﹤0.01% |
6,901
+6,693
| +3,218% | +$2.14M |
|
5172
CALL
iShares MSCI USA Momentum Factor ETF
MTUM
$26.2B
| $2.33M | ﹤0.01% |
11,500
+6,200
| +117% | +$1.2M |
|
5173
PUT
Hess Midstream
HESM
$5.2B
| $2.33M | ﹤0.01% |
66,100
+21,200
| +47% | +$778K |
|
5174
IQ MacKay ESG High Income ETF
IQHI
$114M
| $2.33M | ﹤0.01% |
85,922
+61,993
| +259% | +$1.65M |
|
|
SVC
5175
Service Properties Trust
SVC
$1.05B
| $2.33M | ﹤0.01% |
102,128
+42,596
| +72% | +$1.06M |
|
Similar funds
Ken Griffin's Q3 2024 Portfolio in Review
As of Q3 2024, Ken Griffin held 15,731 positions worth $518B, up 4.9% from $494B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Ken Griffin's Q3 2024 filing shows 1,614 new, 6,434 increased, 5,866 reduced and 1,610 closed positions. Its largest new stake was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M. The largest sale was Invesco QQQ Trust, an estimated $1.43B.
By sector, the portfolio is most concentrated in Technology at 3% of assets, down from 3.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Ken Griffin's largest Q3 2024 buy was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M.
- Ken Griffin added most to NVIDIA in Q3 2024, an estimated $555M increase.
- Ken Griffin's biggest Q3 2024 reduction was Invesco QQQ Trust, cutting an estimated $1.43B.
- Ken Griffin fully exited Domino's in Q3 2024, selling an estimated $186M.
- Ken Griffin's ten largest holdings make up 30% of its $518B portfolio in Q3 2024.
- Ken Griffin opened 1,614 new positions and closed 1,610 in Q3 2024.
- Ken Griffin's portfolio value rose 4.9% quarter-over-quarter to $518B.
Based on Citadel Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.